COMP <GO>
CYH vs MRK // GROSS PROFIT MARGIN
Community Health Systems Inc. (NYSE) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: CYH 2
— MRK 8
▲ GROSS PROFIT MARGIN LEADER: CYH
LAST: $2.40 (-0.41%) • MKT CAP: $339.8M
gross-margins
85.10%
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
gross-margins
74.80%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CYH VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CYH | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 85.10% | 74.80% | +10.30 | CYH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 13.50% | 20.70% | -7.20 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 5.9x | 15.3x | -9.40 | CYH | /valuation <GO> |
| Free Cash Flow Yield | — | 3.42% | — | TIE | /fcf-yield <GO> |
| Operating Margin | 11.90% | 34.30% | -22.40 | MRK | /operating-margins <GO> |
| Net Profit Margin | 4.10% | 28.10% | -24.00 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | -1.20% | 1.30% | -2.50 | MRK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.05 | 5.19 | -4.14 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 29.9 | 51.7 | -21.80 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 18.4x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $339.8M | $361.02B | -$360.68B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CYH REV | MRK REV | CYH GROSS % | MRK GROSS % | CYH FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $12.48B | $65.01B | 85.1% | 74.8% | $208.0M | $12.36B |
| FY 2024 | $12.63B | $64.17B | 84.6% | 76.3% | $120.0M | $18.10B |
| FY 2023 | $12.49B | $60.12B | — | — | $210.0M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CYH // BETA —
MRK // BETA 0.92